Sign in

CIK 0001640266

  • Accelerated filer
  • Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-17 Sandrock Alfred President and CEO Grant or award +120,000 222,055
2023-02-17 Sandrock Alfred President and CEO Grant or award · Stock Option (Right to Buy) +240,000 240,000
2023-02-13 Carter Todd Alfred Chief Scientific Officer Sale −797 $7.67 $6K 34,291
2023-02-13 Hesslein Robert W. Senior VP & General Counsel Sale −2,868 $7.67 $22K 109,907
2023-02-02 Third Rock Ventures III, L.P. 10% owner Other disposition −1,500,000 3,185,291
2023-02-01 Third Rock Ventures III, L.P. 10% owner Sale −128,642 $9.32 $1.2M 4,685,291
2023-01-31 Third Rock Ventures III, L.P. 10% owner Sale −185,000 $9.25 $1.7M 4,813,933
2023-01-30 Third Rock Ventures III, L.P. 10% owner Sale −75,000 $9.03 $677K 4,998,933
2023-01-27 Third Rock Ventures III, L.P. 10% owner Sale −50,000 $9.02 $451K 5,073,933
2023-01-25 Third Rock Ventures III, L.P. 10% owner Sale −50,000 $9.22 $461K 5,123,933
2023-01-24 Third Rock Ventures III, L.P. 10% owner Sale −100,000 $9.27 $927K 5,173,933
2023-01-23 Third Rock Ventures III, L.P. 10% owner Sale −55,000 $9.06 $498K 5,273,933
2023-01-20 Third Rock Ventures III, L.P. 10% owner Sale −100,000 $9.15 $915K 5,328,933
2023-01-17 Hesslein Robert W. Senior VP & General Counsel Sale −1,396 $9.57 $13K 113,567
2023-01-17 Hesslein Robert W. Senior VP & General Counsel Sale −792 $10.34 $8K 112,775
2023-01-17 Carter Todd Alfred Chief Scientific Officer Sale −706 $9.57 $7K 35,488
2023-01-17 Carter Todd Alfred Chief Scientific Officer Sale −400 $10.34 $4K 35,088
2023-01-17 Swartz Robin Chief Operating Officer Sale −1,396 $9.57 $13K 52,695
2023-01-17 Swartz Robin Chief Operating Officer Sale −792 $10.34 $8K 51,903
2023-01-11 EcoR1 Capital, LLC 10% owner Sale −110,000 $8.50 $935K 3,851,507

Page 8 of 19 · 368 trades